# Bioventus restructures $315M CartiHeal acquisition

Bioventus amended its agreement to acquire CartiHeal, reducing the closing payment to $50 million and deferring $215 million into tranches, with the acquisition expected to close by end of July 2022.

- Type: Acquisition
- Announced: 2022-06-23
- Where: United States
- Value: $315.0M
- Status: announced
- Products: orthopedic implants for knee osteoarthritis
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Bioventus Inc.](https://endata.com/companies/54140.md) (acquirer)
- [CartiHeal](https://endata.com/companies/57427.md) (target)

## Sources

- [massdevice.com](https://www.massdevice.com/bioventus-cartiheal-acquisition/), 2022-06-23: "Bioventus amended the agreement for its pending acquisition of CartiHeal to defer a large chunk of payments."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.